Sunday marks the start of this year’s Clinical Year in Review (CYIR) series at the ATS 2026 International Conference, offering a rare opportunity to learn about timely, impactful insights that could significantly affect care.

“The CYIR sessions are where we can see today’s best science translated into decisions that we can make at the bedside tomorrow,” said Ayodeji Adegunsoye, MD, PhD, MSc, professor of medicine at the University of Chicago Medicine.

Dr. Adegunsoye is co-chairing the four highly anticipated CYIR sessions in Orlando with Arun Kannappan, MD, associate professor of medicine at the University of Colorado Anschutz, and Elisabeth Dianne. Riviello, MD, MPH, assistant professor of medicine at Harvard Medical School/Beth Israel Deaconess Medical Center.

Dr. Adegunsoye added, “The CYIR sessions encapsulate new evidence, difficult concepts, unresolved questions around routine patient care, and data that is likely to change and inform practice on a day-to-day basis. What we hope to offer the audience is a practical mental model of what they can start doing in their practice immediately following the ATS meeting — essentially a roadmap of what to start doing, what to stop doing, and then what to watch out for next.”

The first CYIR session, from 9:15–10:45 ET, Sunday, May 17, in the Chapin Theater (Level III, OCCC West Concourse), will include presentations on asthma, pulmonary vascular disease, vaccines, and sleep medicine.

“For the first two days, the theme of the CYIR sessions is a deep dive into the frontline decisions that affect large patient volumes, in conditions that are prevalent in significant proportions of patients across pulmonary, critical care, and sleep medicine,” Dr. Adegunsoye explained.

Dr. Adegunsoye also noted the significance of including vaccines as a focus in this year’s CYIR series, explaining that they have not historically been discussed over the last 15 to 20 years. He clarified, though, that vaccines are important not just in preventive medicine but also in the primary care model across all pulmonary subspecialties,  helping achieve more holistic health across patient populations.

“Our goal is to translate the most clinically actionable evidence into real-world counseling that patients can derive benefit from immediately,” explained Dr. Adegunsoye. “The presentation on vaccines will encompass identification of patients who can benefit from vaccination, how to prioritize vaccines, and strategies for communicating uncertainty, when appropriate and guided by evidence, and to do so responsibly.”

The talk on asthma this year will focus on precision therapy, including how to redefine asthma management, prevent exacerbations, and the role of biologics, as well as new data to guide a treat-to-target approach, Dr. Adegunsoye said.

“In sleep medicine, we will spotlight studies that can impact patient outcomes — including the way patients feel and function, the role of sleep-related function and adherence, and the relationship of sleep health to cardiovascular risk. A particular focus will be the implementation of sleep interventions outside of subspecialty centers,” Dr. Adegunsoye said.

Monday’s CYIR session, also from 9:15–10:45 a.m. ET in the Chapin Theater, will delve into acute respiratory distress syndrome (ARDS) and acute hypoxemic respiratory failure (AHRF), critical care, sepsis, and post-ICU care/ICU rehab.

Dr. Adegunsoye said that while the role of post-ICU care has been discussed in past ATS meetings, the ATS is bringing this topic back to the forefront now, “to emphasize that ICU survival time isn’t really the finish line for our patients. It is in many ways the starting line for our ICU patients.”

The presentation on post-ICU care and rehabilitation will address survivorship and rehabilitation, with discussions on how to better implement guidelines at the bedside.

“The CYIR sessions have consistently elevated long-term post-ICU care aspects, like long COVID, post-ICU care, and recovery science,” Dr. Adegunsoye said. “This year, we will be pushing the conversation towards more structured follow-up for these patients and assessing function in a way that is practical and clinically relevant.”

At the Society of Critical Care Medicine (SCCM) congress in March 2026, new guideline-level practices for daily sepsis care were discussed. The ATS has suggested updates to the guidelines, Dr. Adegunsoye said, which will be explored during the talk on sepsis.

“Throughout this year’s CYIR sessions, we are deliberately balancing big practice-changing trials with how the evidence can be integrated in routine practice in the clinic. A broad spectrum of topics will be covered to help shift the narrative towards precision medicine, earlier action, and patient-centered outcomes,” Dr. Adegunsoye explained.